-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Inmune Bio, Inc. annual/quarterly Operating Margin history and growth rate from Q4 2022 to Q1 2024.
- Inmune Bio, Inc. Operating Margin for the quarter ending March 31, 2024 was -26.2K %, a 152% decline year-over-year.
- Inmune Bio, Inc. annual Operating Margin for 2024 was -305K %, a 1487% decline from 2023.
- Inmune Bio, Inc. annual Operating Margin for 2023 was -19.2K %, a 177% decline from 2022.
- Inmune Bio, Inc. annual Operating Margin for 2022 was -6.94K %, a 56.9% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)